Jeffrey V. Poulton Insider Trading Activity
Jeffrey V. Poulton has been net-selling over the last 12 months with 0 purchases and 58 sales across 1 company.
ALNY is the most-traded position with 58 trades. The largest single transaction was a sale of ALNY for $695K on Feb 13, 2026.
Performance Scorecard
Forward stock performance after each transaction by Jeffrey V. Poulton. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | +4.4% | 71% | 58 |
| 90 days | — | +8.3% | 88% | 58 |
| 120 days | — | +15.7% | 100% | 58 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersALNY · ALNYLAM PHARMACEUTICALS, INC.
🔒 Subscribe to see trade entries
Pro members see exactly when Jeffrey V. Poulton bought and sold ALNY.
Upgrade to ProRecent Trades
Showing the 50 most recent of 58 disclosed trades.
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
Mar 4, 2026 | ALNY | Sell | 114 | $319.03 | $36K | −0.2% | CFO | |
Mar 4, 2026 | ALNY | Sell | 109 | $320.01 | $35K | −0.2% | CFO | |
Mar 4, 2026 | ALNY | Sell | 230 | $320.81 | $74K | −0.4% | CFO | |
Mar 4, 2026 | ALNY | Sell | 309 | $321.82 | $99K | −0.5% | CFO | |
Mar 4, 2026 | ALNY | Sell | 374 | $323.01 | $121K | −0.6% | CFO | |
Mar 4, 2026 | ALNY | Sell | 818 | $323.84 | $265K | −1.3% | CFO | |
Mar 4, 2026 | ALNY | Sell | 291 | $324.88 | $95K | −0.5% | CFO | |
Mar 4, 2026 | ALNY | Sell | 223 | $325.67 | $73K | −0.4% | CFO | |
Mar 2, 2026 | ALNY | Sell | 65 | $323.62 | $21K | −0.1% | CFO | |
Mar 2, 2026 | ALNY | Sell | 124 | $324.65 | $40K | −0.2% | CFO | |
Mar 2, 2026 | ALNY | Sell | 356 | $325.63 | $116K | −0.5% | CFO | |
Mar 2, 2026 | ALNY | Sell | 541 | $326.81 | $177K | −0.8% | CFO | |
Mar 2, 2026 | ALNY | Sell | 454 | $327.67 | $149K | −0.7% | CFO | |
Mar 2, 2026 | ALNY | Sell | 138 | $328.71 | $45K | −0.2% | CFO | |
Mar 2, 2026 | ALNY | Sell | 234 | $329.71 | $77K | −0.4% | CFO | |
Mar 2, 2026 | ALNY | Sell | 112 | $330.85 | $37K | −0.2% | CFO | |
Mar 2, 2026 | ALNY | Sell | 129 | $331.93 | $43K | −0.2% | CFO | |
Mar 2, 2026 | ALNY | Sell | 53 | $332.64 | $18K | −0.1% | CFO | |
Feb 13, 2026 | ALNY | Sell | 2,242 | $310.08 | $695K | −3.6% | CFO | |
Jan 12, 2026 | ALNY | Sell | 72 | $353.95 | $25K | −0.1% | CFO | |
Jan 12, 2026 | ALNY | Sell | 78 | $355.16 | $28K | −0.1% | CFO | |
Jan 12, 2026 | ALNY | Sell | 76 | $356.09 | $27K | −0.1% | CFO | |
Jan 12, 2026 | ALNY | Sell | 176 | $357.17 | $63K | −0.3% | CFO | |
Jan 12, 2026 | ALNY | Sell | 226 | $358.18 | $81K | −0.4% | CFO | |
Jan 12, 2026 | ALNY | Sell | 156 | $359.14 | $56K | −0.3% | CFO | |
Jan 12, 2026 | ALNY | Sell | 284 | $360.22 | $102K | −0.5% | CFO | |
Jan 12, 2026 | ALNY | Sell | 181 | $361.45 | $65K | −0.3% | CFO | |
Jan 12, 2026 | ALNY | Sell | 135 | $362.38 | $49K | −0.2% | CFO | |
Jan 12, 2026 | ALNY | Sell | 87 | $363.55 | $32K | −0.1% | CFO | |
Jan 12, 2026 | ALNY | Sell | 365 | $364.83 | $133K | −0.6% | CFO | |
Jan 12, 2026 | ALNY | Sell | 405 | $365.56 | $148K | −0.7% | CFO | |
Jan 12, 2026 | ALNY | Sell | 92 | $366.41 | $34K | −0.2% | CFO | |
Jan 12, 2026 | ALNY | Sell | 170 | $368.62 | $63K | −0.3% | CFO | |
Jan 12, 2026 | ALNY | Sell | 73 | $369.48 | $27K | −0.1% | CFO | |
Jan 12, 2026 | ALNY | Sell | 36 | $370.87 | $13K | −0.1% | CFO | |
Jan 12, 2026 | ALNY | Sell | 6 | $372.46 | $2K | −0.0% | CFO | |
Jan 12, 2026 | ALNY | Sell | 25 | $374.44 | $9K | −0.0% | CFO | |
Jan 12, 2026 | ALNY | Sell | 34 | $375.65 | $13K | −0.1% | CFO | |
Jan 12, 2026 | ALNY | Sell | 27 | $377.82 | $10K | −0.0% | CFO | |
Oct 2, 2025 | ALNY | Sell | 150 | $446.53 | $67K | −0.3% | CFO | |
Oct 2, 2025 | ALNY | Sell | 73 | $447.92 | $33K | −0.1% | CFO | |
Oct 2, 2025 | ALNY | Sell | 234 | $448.77 | $105K | −0.4% | CFO | |
Oct 2, 2025 | ALNY | Sell | 324 | $449.79 | $146K | −0.6% | CFO | |
Oct 2, 2025 | ALNY | Sell | 704 | $450.81 | $317K | −1.2% | CFO | |
Oct 2, 2025 | ALNY | Sell | 432 | $451.86 | $195K | −0.8% | CFO | |
Oct 2, 2025 | ALNY | Sell | 869 | $452.69 | $393K | −1.6% | CFO | |
Oct 2, 2025 | ALNY | Sell | 428 | $453.77 | $194K | −0.8% | CFO | |
Oct 2, 2025 | ALNY | Sell | 317 | $454.84 | $144K | −0.6% | CFO | |
Oct 2, 2025 | ALNY | Sell | 95 | $455.82 | $43K | −0.2% | CFO | |
Oct 2, 2025 | ALNY | Sell | 191 | $457.43 | $87K | −0.4% | CFO |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | 58 | $5.9M |
Other insiders at ALNYLAM PHARMACEUTICALS, INC.
7 other tracked filers at ALNY.